The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: Goldman Adds BHP Billiton To Conviction Buy List

Thu, 15th Jan 2015 09:49

LONDON (Alliance News) - The following UK shares received analyst recommendations Thursday morning and Wednesday:
----------
FTSE 100
----------
GOLDMAN SACHS RAISES BHP BILLITON TO 'CONVICTION BUY LIST' ('NEUTRAL') - PRICE TARGET 1575 (1870) PENCE
----------
NOMURA CUTS BG GROUP PRICE TARGET TO 900 (1000) PENCE - 'REDUCE'
----------
JEFFERIES CUTS BG GROUP PRICE TARGET TO 1215 (1250) PENCE - 'BUY'
----------
NOMURA CUTS BP PRICE TARGET TO 380 (430) PENCE - 'NEUTRAL'
----------
JEFFERIES CUTS BP PRICE TARGET TO 470 (490) PENCE - 'BUY'
----------
JEFFERIES CUTS SHELL A PRICE TARGET TO 2450 (2540) PENCE - 'BUY'
----------
NOMURA CUTS SHELL B PRICE TARGET TO 2350 (2600) PENCE - 'BUY'
----------
S&P CAPITAL IQ CUTS BHP BILLITON TO 'HOLD' ('BUY') - PRICE TARGET 1300 (1825) PENCE
----------
UBS CUTS BHP BILLITON PRICE TARGET TO 1870 (2000) PENCE - 'BUY'
----------
BARCLAYS CUTS BHP BILLITON PRICE TARGET TO 1500 (2100) PENCE - 'OVERWEIGHT'
----------
S&P CAPITAL IQ RAISES BURBERRY PRICE TARGET TO 1520 (1420) PENCE - 'SELL'
----------
TRADERS: NUMIS CUTS ANTOFAGASTA TO 'REDUCE' ('HOLD')
----------
S&P CAPITAL IQ CUTS ANTOFAGASTA TO 'SELL' ('HOLD') - TARGET 625 (760) PENCE
----------
BARCLAYS CUTS ANTOFAGASTA PRICE TARGET TO 700 (745) PENCE - 'EQUAL WEIGHT'
----------
S&P CAPITAL IQ CUTS RIO TINTO PRICE TARGET TO 2800 (3300) PENCE - 'HOLD'
----------
UBS CUTS RIO TINTO PRICE TARGET TO 3300 (3500) PENCE - 'BUY'
----------
BERNSTEIN RAISES RBS PRICE TARGET TO 470 (450) PENCE - 'OUTPERFORM'
----------
BARCLAYS CUTS ANGLO AMERICAN PRICE TARGET TO 1080 (1550) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS RAISES FRESNILLO PRICE TARGET TO 835 (800) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS RAISES RANDGOLD RESOURCES TARGET TO 5600 (4900) PENCE - 'OVERWEIGHT'
----------
TRADERS: NUMIS CUTS RANDGOLD RESOURCES TO 'HOLD' ('BUY')
----------
BARCLAYS RAISES COMPASS GROUP PRICE TARGET TO 1250 (1180) PENCE - 'OVERWEIGHT'
----------
CS CUTS COMPASS GROUP TO 'NEUTRAL' ('OUTPERFORM') - TARGET 190 PENCE
----------
BARCLAYS RAISES INTERCONTINENTAL HOTELS TARGET TO 2650 (2360) PENCE; 'EQUAL WEIGHT.'
----------
BARCLAYS RAISES WHITBREAD PRICE TARGET TO 5400 (4900) PENCE - 'OVERWEIGHT'
----------
Investec Raises BAT Price Target To 3,600P From 3,400P, Keeps At Hold
----------
EXANE BNP CUTS SKY PLC TO 'NEUTRAL' ('OUTPERFORM') - PRICE TARGET 1000 (985) PENCE
----------
EXANE BNP RAISES GKN PRICE TARGET TO 380 (340) PENCE - 'OUTPERFORM'
----------
EXANE BNP CUTS SMITHS GROUP PRICE TARGET TO 1050 (1150) PENCE - 'NEUTRAL'
----------
EXANE BNP CUTS WEIR GROUP PRICE TARGET TO 1500 (1835) PENCE - 'UNDERPERFORM'
----------
DEUTSCHE BANK RAISES ASTRAZENECA PRICE TARGET TO 4800 (4350) PENCE - 'HOLD'
----------
DEUTSCHE BANK CUTS GLAXOSMITHKLINE PRICE TARGET TO 1300 (1390) PENCE - 'HOLD'
----------
HSBC RAISES EASYJET PRICE TARGET TO 1500 (1450) PENCE - 'UNDERWEIGHT'
----------
HSBC CUTS ADMIRAL GROUP PRICE TARGET TO 1590 (1625) PENCE - 'OVERWEIGHT'
----------
HSBC CUTS RSA INSURANCE PRICE TARGET TO 474 (480) PENCE - 'NEUTRAL'
----------
HSBC CUTS AVIVA PRICE TARGET TO 535 (590) PENCE - 'NEUTRAL'
----------
HSBC RAISES PRUDENTIAL PRICE TARGET TO 1800 (1725) PENCE - 'OVERWEIGHT'
----------
HSBC RAISES DIRECT LINE PRICE TARGET TO 346 (335) PENCE - 'OVERWEIGHT'
----------
HSBC RAISES FRIENDS LIFE PRICE TARGET TO 420 (415) PENCE - 'OVERWEIGHT'
----------
HSBC RAISES LEGAL & GENERAL PRICE TARGET TO 296 (285) PENCE - 'OVERWEIGHT'
----------
HSBC CUTS STANDARD LIFE PRICE TARGET TO 425 (430) PENCE - 'NEUTRAL'
----------
FTSE 250
----------
JPMORGAN RAISES REDEFINE INTERNATIONAL TARGET TO 53 (50) PENCE - 'UNDERWEIGHT'
----------
BERENBERG INITIATES BODYCOTE WITH 'HOLD' - TARGET 684 PENCE
----------
SOCGEN RAISES PROVIDENT FINANCIAL PRICE TARGET TO 2540 (2270) PENCE - 'HOLD'
----------
TRADERS: NUMIS CUTS KAZ MINERALS TO 'REDUCE' ('HOLD')
----------
BARCLAYS CUTS KAZ MINERALS PRICE TARGET TO 150 (255) PENCE - 'EQUAL WEIGHT'
----------
CREDIT SUISSE RAISES LADBROKES TO 'NEUTRAL' ('UNDERPERFORM') - TARGET 115 PENCE
----------
BARCLAYS CUTS LADBROKES PRICE TARGET TO 104 (126) PENCE - 'EQUAL WEIGHT'
----------
CREDIT SUISSE CUTS DOMINO'S PIZZA TO 'NEUTRAL' ('OUTPERFORM') - TARGET 695 (650) PENCE
----------
TRADERS: CITIGROUP RAISES JUPITER FUND TO 'BUY' ('NEUTRAL')
----------
BARCLAYS CUTS LONMIN PRICE TARGET TO 155 (190) PENCE - 'UNDERWEIGHT'
----------
BARCLAYS RAISES ACACIA MINING TO 'OVERWEIGHT' ('EQUAL WEIGHT')
----------
BARCLAYS CUTS PETRA DIAMONDS PRICE TARGET TO 280 (290) PENCE - 'OVERWEIGHT'
----------
BARCLAYS RAISES POLYMETAL TO 'EQUAL WEIGHT' ('UNDERWEIGHT')
----------
BARCLAYS CUTS VEDANTA PRICE TARGET TO 400 (840) PENCE - 'UNDERWEIGHT'
----------
EXANE BNP RAISES TALK TALK TELECOM TARGET TO 220 (200) PENCE - 'UNDERPERFORM'
----------
BARCLAYS RAISES MERLIN ENTERTAINMENTS TARGET TO 450 (420) PENCE - 'OVERWEIGHT'
----------
BARCLAYS CUTS WILLIAM HILL PRICE TARGET TO 390 (400) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS CUTS MARSTONS TO 'UNDERWEIGHT' ('EQUAL WEIGHT') - TARGET 130 (150) PENCE
----------
EXANE BNP RAISES HALMA TO 'OUTPERFORM' ('NEUTRAL') - TARGET 780 (685) PENCE
----------
EXANE BNP RAISES ROTORK TO 'NEUTRAL' ('UNDERPERFORM') - TARGET 2300 PENCE
----------
EXANE BNP CUTS SPECTRIS TO 'UNDERPERFORM' ('NEUTRAL') - TARGET 1825 (1740) PENCE
----------
EXANE BNP RAISES SPIRAX-SARCO TO 'NEUTRAL' ('UNDERPERFORM')
----------
EXANE BNP RAISES SPIRAX-SARCO TARGET TO 2935 (2450) PENCE
----------
EXANE BNP RAISES VESUVIUS TO 'OUTPERFORM' ('NEUTRAL') - TARGET 510 (440) PENCE
----------
BARCLAYS RAISES BETFAIR PRICE TARGET TO 1626 (1576) PENCE - 'OVERWEIGHT'
----------
SOCGEN RAISES BBA AVIATION PRICE TARGET TO 400 (360) PENCE - 'BUY'
----------
HSBC CUTS CATLIN GROUP TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 720 (620) PENCE
----------
HSBC CUTS PHOENIX GROUP TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 875 (870) PENCE
----------
HSBC RAISES AMLIN PRICE TARGET TO 433 (420) PENCE - 'UNDERWEIGHT'
----------
HSBC RAISES ESURE GROUP PRICE TARGET TO 330 (320) PENCE - 'OVERWEIGHT'
----------
HSBC RAISES HISCOX PRICE TARGET TO 715 (690) PENCE - 'NEUTRAL'
----------
HSBC RAISES LANCASHIRE HLDGS PRICE TARGET TO 655 (650) PENCE - 'OVERWEIGHT'
----------
MAIN MARKET AND AIM
----------
UBS CUTS FENNER PRICE TARGET TO 210 (235) PENCE - 'NEUTRAL'
----------
UBS CUTS PREMIER OIL PRICE TARGET TO 200 (300) PENCE - 'BUY'
----------
TRADERS: NUMIS CUTS PETROPAVLOVSK TO 'SELL' ('REDUCE')
----------
BARCLAYS CUTS FERREXPO TO 'UNDERWEIGHT' ('EQUAL WEIGHT.') - TARGET 50 (140) PENCE
----------
BARCLAYS CUTS GEM DIAMONDS PRICE TARGET TO 245 (260) PENCE - 'OVERWEIGHT'
----------
BARCLAYS RAISES HOCHSCHILD MINING TO 'OVERWEIGHT' ('EQUAL WEIGHT')
----------
PANMURE RAISES SQS SOFTWARE PRICE TARGET TO 590 (527) PENCE - 'HOLD'
----------
HSBC RAISES FLYBE GROUP PRICE TARGET TO 150 (140) PENCE - 'OVERWEIGHT'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.